Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for blood loss reduction in total hip arthroplasty for hip fracture
ChiCTR1800015809Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in hip fracture (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Blood measurement, Function and 3 more. Started May 2018; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
hip fracture
Beyond the preview
Go deeper on ChiCTR1800015809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015809.